IGF1 and breast carcinoma: IGFBP3, which is a key regulatory molecule in the IGF axis and could be either tumor suppressor or promoter in different tumor types, was reported to be highly expressed in aggressive breast cancer, advanced stage of melanoma, and higher in metastatic than non-metastatic tumors in pancreatic endocrine neoplasms30.